Literature DB >> 25708798

Contemporary surgical options for metastatic colorectal cancer.

Zhifei Sun1, Julie M Thacker.   

Abstract

The diagnosis of stage IV colorectal cancer was once associated with a uniformly grim prognosis. Over the last 20 years, advances in chemotherapeutics, surgical technique, and surgical adjuncts have dramatically broadened treatment options and improved outcomes. Among current treatment options, surgery remains the key component of any multidisciplinary approach with surgical data demonstrating the longest survivorship. This review will summarize current and developing surgical advances in the treatment of metastatic colorectal cancer. Specifically, we will discuss how surgical interventions fit within the greater context of a multi-modality approach, as well as, the specific, recent innovations in the surgical management of hepatic and extrahepatic metastases.

Entities:  

Mesh:

Year:  2015        PMID: 25708798     DOI: 10.1007/s11912-015-0437-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  48 in total

1.  Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Authors:  Frank A Scappaticci; Louis Fehrenbacher; Thomas Cartwright; John D Hainsworth; William Heim; Jordan Berlin; Fairooz Kabbinavar; William Novotny; Somnath Sarkar; Herbert Hurwitz
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

2.  Premature closure of the Dutch Stent-in I study.

Authors:  J E van Hooft; P Fockens; A W Marinelli; P M Bossuyt; W A Bemelman
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

Review 3.  Strategies for safer liver surgery and partial liver transplantation.

Authors:  Pierre-Alain Clavien; Henrik Petrowsky; Michelle L DeOliveira; Rolf Graf
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

4.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

5.  Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Authors:  G Folprecht; A Grothey; S Alberts; H-R Raab; C-H Köhne
Journal:  Ann Oncol       Date:  2005-05-03       Impact factor: 32.976

6.  Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma.

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi; Giuseppe Tonini; Patrizio Bollero; Mario Roselli; Davide Mineo; Italo Nofroni
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

7.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

8.  Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.

Authors:  Mechteld C de Jong; Skye C Mayo; Carlo Pulitano; Serena Lanella; Dario Ribero; Jennifer Strub; Catherine Hubert; Jean-François Gigot; Richard D Schulick; Michael A Choti; Luca Aldrighetti; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2009-10-01       Impact factor: 3.452

Review 9.  Expanding criteria for resectability of colorectal liver metastases.

Authors:  Timothy M Pawlik; Richard D Schulick; Michael A Choti
Journal:  Oncologist       Date:  2008-01

10.  Endoscopic obstruction is associated with higher risk of acute events requiring emergency operation in colorectal cancer patients.

Authors:  Virote Chalieopanyarwong; Teeranut Boonpipattanapong; Paradee Prechawittayakul; Surasak Sangkhathat
Journal:  World J Emerg Surg       Date:  2013-09-08       Impact factor: 5.469

View more
  3 in total

Review 1.  [Prognostic biomarkers for metastatic colorectal cancer].

Authors:  J H L Neumann
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

2.  Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy.

Authors:  Jing Yang; Xinli Guo; Tong Wu; Kaifan Niu; Xuelei Ma
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

3.  Complete Radiologic Response of Metastatic Pancreatic Ductal Adenocarcinoma to Microwave Ablation Combined with Second-Line Palliative Chemotherapy.

Authors:  Hakon Blomstrand; Karin Adolfsson; Per Sandström; Bergthor Björnsson
Journal:  Case Rep Gastrointest Med       Date:  2020-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.